mRNA Vaccine and Therapeutics Market By Product (Prophylactic Vaccines, Therapeutic Vaccines, Therapeutic Drugs, and Others), Disease Type (Acute Hepatic Porphyria, Primary Hyperoxaluria Type 1, Hereditary Transthyretin-mediated Amyloidosis Genetic, Atherosclerotic Cardiovascular Disease, Others), Treatment Type (Monoclonal Antibody, Gene Therapy, Cell Therapy, and Others), Route of Delivery (Intradermal, Subcutaneous, Intramuscular, Intravenous, and Intranodal), Application (Rare Genetic Diseases, Oncology, Respiratory Diseases, Infectious Diseases, and Others), End-use (Hospitals & Clinics, Research Laboratories & Organizations, and Others), and Region - Market Perspective, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecast for 2023 – 2030 |
USD
3499
|